Connect
MJA
MJA

Substance misuse in patients with schizophrenia: a primary care guide

Dan I Lubman and Suresh Sundram
Med J Aust 2003; 178 (9 Suppl): S71-S75.

Summary

  • Smoking presents a substantial health and economic burden to people with schizophrenia.

  • Comorbid use of other substances is common, under-recognised, and associated with a number of serious adverse consequences, such as psychotic relapse and poorer social outcomes.

  • All patients with schizophrenia need to be screened for substance misuse.

  • Effective interventions involve integrated, modified pharmacological and psychosocial strategies.

Please login with your free MJA account to view this article in full

  • Dan I Lubman1
  • Suresh Sundram2

  • 1 Orygen Research Centre and Cognitive Neuropsychiatry Research and Academic Unit, University of Melbourne, Melbourne, VIC.
  • 2 Mental Health Research Institute, Melbourne, VIC.

Correspondence: dan.lubman@mh.org.au

Acknowledgements: 

Dr Lubman is supported by the Norma Licht Trust.

Competing interests:

S S has received honoraria from Eli Lilly and AstraZeneca. D I L has received conference support from Pfizer, Eli Lilly and AstraZeneca.

  • 1. George TP, Ziedonis DM, Feingold A, et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry 2000; 157: 1835-1842.
  • 2. Brown S, Inskip H, Barraclough B. Causes of the excess mortality of schizophrenia. Br J Psychiatry 2000; 177: 212-217.
  • 3. Cantor-Graae E, Nordstrom LG, McNeil TF. Substance abuse in schizophrenia: a review of the literature and a study of correlates in Sweden. Schizophr Res 2001; 48: 69-82.
  • 4. Dixon L. Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res 1999; 35 Suppl: S93-S100.
  • 5. Fowler IL, Carr VJ, Carter NT, Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. Schizophr Bull 1998; 24: 443-455.
  • 6. Chick J, Cantwell R, editors. Seminars in alcohol and drug misuse. London: Gaskell; 1994.
  • 7. Woody G, Schuckit M, Weinrieb R, Yu E. A review of the substance use disorders section of the DSM-IV. Psychiatr Clin North Am 1993; 16: 21-32.
  • 8. Krystal JH, D'Souza DC, Madonick S, Petrakis IL. Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients. Schizophr Res 1999; 35 Suppl: S35-S49.
  • 9. Lambert T, Castle DJ. Pharmacological approaches to the management of schizophrenia. Med J Aust 2003; 178 Suppl May 5: S57-S61.<eMJA full text>
  • 10. Spencer C, Castle D, Michie PT. Motivations that maintain substance use among individuals with psychotic disorders. Schizophr Bull 2002; 28: 233-247.
  • 11. McNeill A. Smoking and mental health: a review of the literature. SmokeFree London Programme, December 2001. Available at: http://www.ash.org.uk/html/policy/menlitrev.html (accessed Jan 2003).
  • 12. Peters MJ, Morgan LC. The pharmacotherapy of smoking cessation. Med J Aust 2002; 176: 486-490. <eMJA full text>
  • 13. Smith J, Hucker S. Schizophrenia and substance abuse. Br J Psychiatry 1994; 165: 13-21.
  • 14. Drake RE, Mueser KT. Psychosocial approaches to dual diagnosis. Schizophr Bull 2000; 26: 105-118.
  • 15. Ziedonis DM, D'Avanzo K. Schizophrenia and substance abuse. In: Kranzler HR, Rounsaville BJ, editors. Dual diagnosis and treatment: substance abuse and comorbid medical and psychiatric disorders. New York: Marcel Dekker, 1998: 427-465.
  • 16. O'Neill MM. Countertransference and attitudes in the context of clinical work with dually diagnosed patients. In: Solomon J, Zimberg S, Shollar E, editors. Dual diagnosis: evaluation, treatment, training, and program development. New York: Plenum Press, 1993: 127-146.
  • 17. George TP, Vessicchio JC, Termine A, et al. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry 2002; 52: 53-61.
  • 18. Miller W, Rollnick S. Motivational interviewing: preparing people to change addictive behaviours. New York: Guildford, 1991.
  • 19. Prochaksa JO, DiClemente CC, Norcross JC. In search of how people change: applications to addictive disorders. Am Psychol 1992; 47: 1102-1114.
  • 20. Marlatt G, Gordon J. Relapse prevention: maintenance strategies in the treatment of addictive behaviours. New York: Guildford Press, 1985.

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.